{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039574","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2024-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.016880+00:00","generated_at":"2026-05-30T20:42:18.242581+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PowerUp Acquisition Corp. agrees to pay sponsor $1M fee upon closing of Aspire Biopharma deal","bullets":["Sponsor SRIRAMA Associates to receive $1M modified promissory note fee upon successful closing of Aspire Biopharma business combination.","Original $2M fee from terminated Visiox BCA replaced by this $1M fee.","Fee included as Purchaser Expenses in the Aspire BCA dated August 26, 2024.","Agreement dated October 2, 2024 between SPAC and Sponsor."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039574","json":"https://secwatch.observer/filing/0001493152-24-039574.json","markdown":"https://secwatch.observer/filing/0001493152-24-039574.md","text":"https://secwatch.observer/filing/0001493152-24-039574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/0001493152-24-039574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T20:42:18.242581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}